Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Champions Oncology, Inc.

TRADE

NASDAQ: CSBRHealthcare / Biotechnology / USA
12.14-0.36-2.88%Vol 103 7061Y Perf 249.71%
Nov 14th, 2018 14:28
BID12.10 ASK12.27
Open12.61 Previous Close12.50
Pre-Market12.95 After-Trading-
 0.45 3.60%  - -%
Target Price
14.33 
Analyst Rating
Strong Buy 1.00
Potencial %
16.88 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/25 
Value Ranking
     19.27
Insiders Value % 3/6/12M
-100/-100/-94 
Growth Ranking
     36.64
Insiders Shares Cnt. % 3/6/12M
-100/-100/-75 
Income Ranking
 —    -
Market Cap (mil)135 
Earnings Rating
Neutral
Price Range Ratio 52wk %
61.21 
Earnings Date
6th Dec 2018

Today's Price Range

12.0012.91

 

52wk Range

3.0517.90

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
4.69%
3 Months
60.46%
6 Months
194.12%
1 Year
249.71%
3 Years
171.74%
5 Years
-4.43%

Quotes

Name / TickerPriceChg.Chg.%
CSBR12.14-0.3600-2.88
AAPL186.96-5.2700-2.74
GOOG1 039.973.92000.38
MSFT105.43-1.5100-1.41
XOM76.95-1.0500-1.35
WFC51.98-0.7600-1.44
JNJ144.27-0.4100-0.28
FB143.030.87000.61
GE8.30-0.3100-3.60
JPM106.93-2.6600-2.43
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.70
Current Ratio 0.70
Long Term Debt to Total Capital 0.20
Total Debt to Equity 0.47
Interest Coverage -
Leverage Ratio 27.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin48.70
EBIT Margin-1.20
EBITDA Margin0.80
Pre-tax Profit Margin-71.00
Profit Margin-1.39
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 255.93
PS Ratios 9.49
Price to Cash Flow 148.70
Price to Free Cash Flow 527.60
Cash Flow Per Share 0.09
Price to Tangible Book-2 299.54
Book Value per Share0.05
Enterprise Value (in ths.)153 338
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-539.20
ROE last 12 Months -71.75
Return on Assets (5Y Avg) -105.86
ROA last 12 Months -4.31
Return on Capital (5Y Avg) -686.98
ROC last 12 Months -43.78
Return on invested Capital Q 82.04
Return on invested Capital Y-732.51
Assets Turnover0.90
Receivables Turnover2.40
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)16 229
Revenue per Share 1.45
Revenue Growth 3 Years 20.44
Revenue Growth 5 Years 13.54
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 20190.000.04-
Q04 2018-0.04-0.06-50.00
Q04 2016--0.30-
Q03 2016--0.28-
Q02 2016--0.29-
Q01 2016--0.33-
Q04 2015--0.05-
Q03 2015--0.04-
Earnings Per EndEstimateRevision %Trend
10/2018 QR0.04300.00Positive
1/2019 QR0.04300.00Positive
4/2019 FY0.17240.00Positive
4/2020 FY0.2525.00Positive
Next Report Date6th Dec 2018
Estimated EPS Next Report0.04
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume103 706
Shares Outstanding (in ths.)11 160
Trades Count561
Dollar Volume1 222 581
Avg. Volume113 355
Avg. Weekly Volume92 900
Avg. Monthly Volume134 410
Avg. Quarterly Volume264 272

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

30%70%

Bearish Bullish

42%58%

Bearish Bullish

52%48%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x